CRISPR Method Successfully Developed for Medicinal FungusAugust 24, 2022
Scientists from the Hunan University of Chinese Medicine reported the first successful genome editing of Poria cocos using CRISPR-Cas9 system integrating genome-wide off-target prediction and detection. Their findings are expected to support future researchers of the genetic breeding and commercial production of edible and medicinal fungi.
Previous researchers using CRISPR-Cas9 have not identified endogenous RNA polymerase III promoters in P. cocos, hence there is little information known about its gene functional analysis. However, a new study identified the endogenous U6 promoters from the available P. cocos genome data. Scientists used the promoter sequence to construct a sgRNA expression vector Pfc332-PcU6 and developed a protoplast isolation protocol afterward. This allowed them to transform the sgRNA-Cas9 vector into the cells of P. cocos using the PEG/CaCl2-mediated transformation approach and identify off-target sites. They also observed that gene editing efficiency was site-dependent. The scientists successfully disrupted the target marker gene ura3 using the CRISPR-Cas9 system. The findings provide opportunities for genome editing research in medicinal fungus.
Learn more in Frontiers in Microbiology.
You might also like:
- Filamentous Fungus may Effectively Control Sugarcane Nematodes
- Bacteria that Kills Fungus Affecting Sugarcane Yields Discovered
- Friendly Fungus Tapped to Induce Pest Resistance in Beans, Cassava
The Crop Biotech Update is a weekly newsletter of ISAAA, a not-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
Research and Tools
- Enhanced Green Fluorescent Marker Effective in Transforming Grapes Using CRISPR
- UC San Diego Researchers Use CRISPR to Target Global Crop Pest
- CRISPR Method Successfully Developed for Medicinal Fungus
- CRISPR-Based Test Enables Fast and Accurate Detection of SARS-CoV-2 Variants
- FDA Approves CRISPR-based Therapeutic for Trial
Trends and Impact
- CRISPR Market Size to Reach US$3.73B by 2032
Read the latest:
- Crop Biotech Update (January 25, 2023)
- Genome Editing Supplement (January 18, 2023)
- Gene Drive Supplement (January 25, 2023)
Subscribe to CBU: